Online Only Articles

SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype

Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Hematology and Hemotherapy Center, National Institute of Blood, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA;Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Department of Pulmonary, Allergy and Critical Care Medicine, Cleveland Clinic, Respiratory Institute, Cleveland, OH, USA
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
Vol. 98 No. 9 (2013): September, 2013 https://doi.org/10.3324/haematol.2013.090506